Mouse suppressyn-like 1 suppresses membrane fusion through envelope glycoprotein recognition

Abstract

Cell-cell fusion is essential for placental development and is mediated by endogenous retrovirus (ERV)-derived fusogens known as syncytins. However, how ERV-derived proteins negatively regulate membrane fusion remains largely unknown. Here, we identify a previously uncharacterized murine ERV envelope-derived protein, mouse suppressyn-like 1 (mSUPYNL1), that suppresses syncytin-mediated membrane fusion through a mechanism distinct from that of placental human suppressyn (hSUPYN). Unlike hSUPYN, which acts through receptor interference, mSUPYNL1 inhibits both murine and human syncytin-mediated fusion independently of receptor usage by associating with the surface (SU) subunits of multiple syncytin envelope glycoproteins, revealing a receptor-independent mechanism of fusion suppression. This mechanism extends beyond endogenous fusogens. mSUPYNL1 also associates with the SU glycoprotein (gp46) of Human T-cell Leukemia Virus type 1 (HTLV-1) and suppresses Env-dependent syncytium formation, whereas hSUPYN showed no detectable antiviral activity in this assay. These findings identify mSUPYNL1 as a broad-spectrum inhibitor of envelope glycoprotein-mediated membrane fusion. Analysis of mSUPYNL1 knockout mice revealed that, in contrast to the placenta-restricted expression of hSUPYN, mSUPYNL1 was broadly expressed, with its most prominent localization in decidual stromal and vascular endothelial cells of the pregnant uterus, as well as in hematopoietic tissues such as the spleen and thymus. Together, our findings uncover an evolutionarily distinct class of ERV-derived fusion suppressors that function through envelope glycoprotein recognition instead of receptor interference. Our study expands current models of ERV domestication by demonstrating that retroviral envelope proteins have been independently co-opted not only to promote membrane fusion but also to restrain it, thereby linking placental biology, antiviral defense, and host evolution. HIGHLIGHTSO_LImSUPYNL1 is an endogenous retrovirus-derived membrane fusion inhibitor C_LIO_LImSUPYNL1 binds the SU domains of murine and human syncytins C_LIO_LImSUPYNL1 suppresses HTLV-1 Env-mediated syncytium formation C_LIO_LIDirect envelope recognition enables receptor-independent fusion inhibition C_LI